Biomed mainz
WebApr 4, 2024 · BERKELEY, Calif. and MAINZ, Germany, April 04, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that three German-based companies have selected ColoAlert ®, the … WebApr 10, 2024 · ColoAlert Revenue Increases 130% Year over Year. Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ ...
Biomed mainz
Did you know?
WebMainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily identify the early onset of ... Web21 hours ago · The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mainz Biomed B.V. with a $18.00 average price target, which is a 208.85% upside from current levels.
Web21 hours ago · The company has a one-year high of $14.80 and a one-year low of $5.42. Currently, Mainz Biomed B.V. has an average volume of 42.73K. TipRanks has tracked … WebOct 28, 2024 · About. Mainz Biomed B.V. ( NASDAQ: MYNZ) is a molecular genetics cancer diagnostic company incorporated in 2024. Mainz Biomed was formed to acquire …
WebMar 8, 2024 · Mainz Biomed is supporting this year’s Gastro Update, a series of two 2-day practical training events for healthcare professionals, led by renowned German … WebOct 28, 2024 · Mainz BioMed develops market-ready molecular genetic diagnostic solutions for life-threatening... Mainz Biomed B.V. Sirius Gutenberg Park Robert-Koch-Straße 50 55129, Mainz, Germany
WebApr 10, 2024 · Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular ...
WebApr 10, 2024 · Mainz Biomed B.V. press release ( NASDAQ: MYNZ ): FY GAAP EPS of -$1.86. Revenue of $0.53M (-8.6% Y/Y). Recommended For You Medical Properties … daniel layish md orlandoWebApr 10, 2024 · ColoAlert Revenue Increases 130% Year over Year Year End Cash Balance of $17.1 Million . BERKELEY, US – MAINZ, Germany – April 10, 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today … daniel layne church of godWebNov 5, 2024 · Happy New Year from the Mainz Biomed team! May 2024 bring you and yours good health and happiness! #HappyNewYear #2024. 1. 1. 2. Mainz BioMed (NASDAQ: MYNZ) birth certificate trust ukWebMainz Biomed B.V. Ordinary Shares (MYNZ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. danielle alex of diversity kitchenWebJan 3, 2024 · Mainz BioMed NV. BERKELEY, US and MAINZ, Germany , Jan. 03, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic ... birth certificate value lookupWebApr 10, 2024 · Early identification of Cancer saves lives. To be effective, cancer detection needs to be simple, readily available, and affordable. We develop innovative products … OUR BUSINESS CONCEPT & PIPELINE SAVES LIVES AND HEALTH CARE … COLOALERT TARGET CONDITION COLORECTAL CANCER 37 … Mainz BioMed is developing proprietary genetic testing methods for pancreatic … NEWS English / EnglischGerman / Deutsch All Corporate News All All Corporate … CONTACT CONTACT US To contact us send us a message using the form or … CAREERS CAREERS At Mainz BioMed, every day is about making a difference … danielle alvarado fair work centerWebFeb 21, 2024 · Anne Hennecke/Caroline Bergmann. +49 211 529252 20. [email protected]. In the US: Spectrum Science. Melissa Laverty/Valerie Enes. +1 540 272 6465. [email protected]. For investor ... birth certificate vellore corporation